McKesson Europe AG
XHAM:CLS1
McKesson Europe AG
Cost of Revenue
McKesson Europe AG
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
McKesson Europe AG
XHAM:CLS1
|
Cost of Revenue
-€8.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
Medios AG
XETRA:ILM1
|
Cost of Revenue
-€1.7B
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
Haemato AG
XETRA:HAEK
|
Cost of Revenue
-€226.5m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
See Also
What is McKesson Europe AG's Cost of Revenue?
Cost of Revenue
-8.5B
EUR
Based on the financial report for Mar 31, 2022, McKesson Europe AG's Cost of Revenue amounts to -8.5B EUR.
What is McKesson Europe AG's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
15%
Over the last year, the Cost of Revenue growth was -9%. The average annual Cost of Revenue growth rates for McKesson Europe AG have been 17% over the past three years , 15% over the past five years .